Tag: Big Pharma
Business & Industry
Revvity and Lilly Expand Lilly TuneLab Access via Signals
Revvity, Inc. announced a collaboration with Eli Lilly and Company to broaden access to Lilly TuneLab by bringing the platform to the Revvity Signals...
Clinical Trials
B-Well 1 And B-Well 2 Phase III Trials Fare Well from GSK
GSK plc has announced positive results coming from its two pivotal phase III trials - the B-Well 1 and B-Well 2 phase III trials,...
Business & Industry
InduPro, Lilly Partner to Discover Novel Cancer Treatments
Shortly after going ahead and securing a partnership with Sanofi, InduPro is now linking up with Eli Lilly in its endeavors to discover novel...
Business & Industry
Nimbus, Lilly Ink Licence Agreement on Treatments in Obesity
Nimbus Therapeutics has announced that it has entered into a multi-year research partnership and a $1.3 billion exclusive license agreement with Eli Lilly in...
Business & Industry
J&J Acquires Clinical-Stage Biotechnology Firm for $3.05bn
Johnson & Johnson - J&J has completed the acquisition of Halda Therapeutics which is a clinical-stage biotechnology firm for an amount of $3.05bn in cash.
This...
BioPharma
AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio
AstraZeneca has gone ahead and committed $100 million to head deeper into the KRAS space by way of securing the right when it comes...
Business & Industry
Novartis to Lower Innovative Medicines Price in the US
Novartis, which is a leading global innovative medicines company, went ahead and announced on December 19, 2025, that it has reached an agreement along with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















